Vascular Response to Experimental Stent Malapposition and Under-Expansion.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26732391)

Published in Ann Biomed Eng on January 05, 2016

Authors

Caroline C O'Brien1, Augusto C Lopes2, Kumaran Kolandaivelu2,3, Mie Kunio2, Jonathan Brown2, Vijaya B Kolachalama2,3,4, Claire Conway2, Lynn Bailey5, Peter Markham5, Marco Costa6, James Ware7, Elazer R Edelman2,3

Author Affiliations

1: Institute of Medical Engineering and Science, Massachusetts Institute of Technology, 77 Massachusetts Avenue, E25-449, Cambridge, MA, 02139, USA. ccob@mit.edu.
2: Institute of Medical Engineering and Science, Massachusetts Institute of Technology, 77 Massachusetts Avenue, E25-449, Cambridge, MA, 02139, USA.
3: Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
4: Charles Stark Draper Laboratory, 555 Technology Square, Cambridge, MA, USA.
5: CBSET, Lexington, MA, USA.
6: University Hospitals, Cleveland, OH, USA.
7: Harvard School of Public Health, Boston, MA, USA.

Articles cited by this

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA (2005) 9.81

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention (2015) 4.00

Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med (2010) 3.27

Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation (2003) 2.72

Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation (2008) 2.64

Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. JACC Cardiovasc Interv (2009) 2.64

A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. JACC Cardiovasc Interv (2009) 2.30

Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study) Eur Heart J (1998) 1.95

Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study. EuroIntervention (2012) 1.85

Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol (2005) 1.73

Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation. Circ Cardiovasc Interv (2014) 1.62

Late coronary stent thrombosis. Circulation (2007) 1.54

Optimal stent-sizing with intravascular ultrasound contributes to complete neointimal coverage after sirolimus-eluting stent implantation assessed by angioscopy. JACC Cardiovasc Interv (2009) 1.53

Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol (2004) 1.53

Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation (2002) 1.45

Drug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation. Circ Cardiovasc Interv (2008) 1.44

Arterial remodeling and coronary artery disease: the concept of "dilated" versus "obstructive" coronary atherosclerosis. J Am Coll Cardiol (2001) 1.36

Automatic segmentation of in-vivo intra-coronary optical coherence tomography images to assess stent strut apposition and coverage. Int J Cardiovasc Imaging (2011) 1.36

Incomplete stent apposition causes high shear flow disturbances and delay in neointimal coverage as a function of strut to wall detachment distance: implications for the management of incomplete stent apposition. Circ Cardiovasc Interv (2014) 1.33

Elastic behavior of porcine coronary artery tissue under uniaxial and equibiaxial tension. Ann Biomed Eng (2004) 1.08

Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry. EuroIntervention (2015) 1.05

Automatic vessel lumen segmentation and stent strut detection in intravascular optical coherence tomography. Med Phys (2012) 0.99

Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography. Circ Cardiovasc Interv (2012) 0.95

Heavily calcified coronary lesions preclude strut apposition despite high pressure balloon dilatation and rotational atherectomy: in-vivo demonstration with optical coherence tomography. Circ J (2008) 0.95

Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! intervention study. JACC Cardiovasc Interv (2008) 0.93

Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol (2014) 0.90

Time course and mechanism of early luminal diameter loss after percutaneous transluminal coronary angioplasty. Am J Cardiol (1995) 0.85

A clinical risk score for prediction of stent thrombosis. Am J Cardiol (2008) 0.84

Regional differences in elastic recoil after percutaneous transluminal coronary angioplasty: a quantitative angiographic study. J Am Coll Cardiol (1991) 0.83

Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography. Circ Cardiovasc Interv (2012) 0.78